Sampurna Chatterjee

1.4k total citations
17 papers, 540 citations indexed

About

Sampurna Chatterjee is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Sampurna Chatterjee has authored 17 papers receiving a total of 540 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Sampurna Chatterjee's work include Lung Cancer Treatments and Mutations (4 papers), Angiogenesis and VEGF in Cancer (3 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Sampurna Chatterjee is often cited by papers focused on Lung Cancer Treatments and Mutations (4 papers), Angiogenesis and VEGF in Cancer (3 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Sampurna Chatterjee collaborates with scholars based in United States, Germany and Austria. Sampurna Chatterjee's co-authors include Morris F. White, Steven E. Shoelson, Manas K. Chaudhuri, Roland T. Ullrich, Lukas C. Heukamp, Bernd Neumaier, Jakob Schöttle, Caroline Wieczorek, Katharina König and Daniel Rauh and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and The Journal of Experimental Medicine.

In The Last Decade

Sampurna Chatterjee

16 papers receiving 533 citations

Peers

Sampurna Chatterjee
Elena E. Tchekneva United States
Alexis S. Lopez United States
Nazanin Majd United States
Amar Desai United States
Elena E. Tchekneva United States
Sampurna Chatterjee
Citations per year, relative to Sampurna Chatterjee Sampurna Chatterjee (= 1×) peers Elena E. Tchekneva

Countries citing papers authored by Sampurna Chatterjee

Since Specialization
Citations

This map shows the geographic impact of Sampurna Chatterjee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sampurna Chatterjee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sampurna Chatterjee more than expected).

Fields of papers citing papers by Sampurna Chatterjee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sampurna Chatterjee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sampurna Chatterjee. The network helps show where Sampurna Chatterjee may publish in the future.

Co-authorship network of co-authors of Sampurna Chatterjee

This figure shows the co-authorship network connecting the top 25 collaborators of Sampurna Chatterjee. A scholar is included among the top collaborators of Sampurna Chatterjee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sampurna Chatterjee. Sampurna Chatterjee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Nia, Hadi T., Meenal Datta, Ashwin S. Kumar, et al.. (2025). Solid Stress Estimations via Intraoperative 3D Navigation in Patients with Brain Tumors. Clinical Cancer Research. 31(16). 3571–3580. 1 indexed citations
2.
Dhiman, Abhijeet, Sampurna Chatterjee, Manish Tripathi, et al.. (2025). Aptamer-Based Diagnosis for Plasmodium vivax Specific Malaria. ACS Infectious Diseases. 11(3). 762–772.
3.
Lei, Pin‐Ji, Ethel R. Pereira, Zohreh Amoozgar, et al.. (2023). Cancer cell plasticity and MHC-II–mediated immune tolerance promote breast cancer metastasis to lymph nodes. The Journal of Experimental Medicine. 220(9). 35 indexed citations
4.
Le, Xiuning, Monique B. Nilsson, Sampurna Chatterjee, et al.. (2023). Abstract B153: Resistance mechanisms to mobocertinib in treating NSCLC with EGFR exon 20 insertion mutations. Molecular Cancer Therapeutics. 22(12_Supplement). B153–B153. 1 indexed citations
5.
Vincent, Sylvie, Zhenqiang Su, Veronica Bunn, et al.. (2022). Molecular analysis of circulating tumor DNA (ctDNA) in patients (pts) with EGFR exon 20 insertion-positive (ex20ins+) advanced NSCLC treated with mobocertinib.. Journal of Clinical Oncology. 40(16_suppl). 9108–9108. 2 indexed citations
6.
Jain, Rakesh K., Nilesh P. Talele, Heena Kumra, et al.. (2022). 1241 IL-1 blockade prevents cardiac toxicity and improves immunotherapy efficacy in mouse models of pancreatic cancer. Regular and Young Investigator Award Abstracts. A1286–A1286. 1 indexed citations
7.
Nia, Hadi T., Ashwin S. Kumar, Meenal Datta, et al.. (2022). NIMG-108. PHYSICAL STRESSES IN BRAIN TUMORS. Neuro-Oncology. 24(Supplement_7). vii190–vii190. 1 indexed citations
8.
Kwanten, Wilhelmus J., Jessica A. Carr, Ivy X. Chen, et al.. (2020). Non-invasive monitoring of chronic liver disease via near-infrared and shortwave-infrared imaging of endogenous lipofuscin. Nature Biomedical Engineering. 4(8). 801–813. 51 indexed citations
9.
Kwanten, Wilhelmus J., Jessica A. Carr, Ivy X. Chen, et al.. (2020). Author Correction: Non-invasive monitoring of chronic liver disease via near-infrared and shortwave-infrared imaging of endogenous lipofuscin. Nature Biomedical Engineering. 4(12). 1222–1222. 2 indexed citations
10.
Askoxylakis, Vasileios, Mark Badeaux, Sylvie Roberge, et al.. (2017). A cerebellar window for intravital imaging of normal and disease states in mice. Nature Protocols. 12(11). 2251–2262. 19 indexed citations
11.
Schöttle, Jakob, Sampurna Chatterjee, Alexandra Florin, et al.. (2015). Intermittent high-dose treatment with erlotinib enhances therapeutic efficacy in EGFR-mutant lung cancer. Oncotarget. 6(36). 38458–38468. 16 indexed citations
12.
Chatterjee, Sampurna, Caroline Wieczorek, Jakob Schöttle, et al.. (2014). Transient Antiangiogenic Treatment Improves Delivery of Cytotoxic Compounds and Therapeutic Outcome in Lung Cancer. Cancer Research. 74(10). 2816–2824. 28 indexed citations
13.
Chatterjee, Sampurna, Lukas C. Heukamp, Jakob Schöttle, et al.. (2013). Tumor VEGF:VEGFR2 autocrine feed-forward loop triggers angiogenesis in lung cancer. Journal of Clinical Investigation. 123(4). 1732–1740. 164 indexed citations
14.
Rothe, Achim, Ron D. Jachimowicz, Sven Borchmann, et al.. (2013). The bispecific immunoligand ULBP2‐aCEA redirects natural killer cells to tumor cells and reveals potent anti‐tumor activity against colon carcinoma. International Journal of Cancer. 134(12). 2829–2840. 51 indexed citations
15.
Chatterjee, Sampurna, Lukas C. Heukamp, Jakob Schöttle, et al.. (2013). Tumor VEGF:VEGFR2 autocrine feed-forward loop triggers angiogenesis in lung cancer. Journal of Clinical Investigation. 123(7). 3183–3183. 15 indexed citations
16.
Shoelson, Steven E., Sampurna Chatterjee, Manas K. Chaudhuri, & Morris F. White. (1992). YMXM motifs of IRS-1 define substrate specificity of the insulin receptor kinase.. Proceedings of the National Academy of Sciences. 89(6). 2027–2031. 150 indexed citations
17.
Chatterjee, Sampurna. (1960). GONIO-VESSELS IN NORMAL AND ABNORMAL EYES. British Journal of Ophthalmology. 44(6). 347–352. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026